Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Kythera Biopharmaceuticals Inc Announces Pricing Of Public Offering Of Common Stock

Tuesday, 8 Oct 2013 07:44pm EDT 

Kythera Biopharmaceuticals Inc announced the pricing of an underwritten public offering of 2,622,950 shares of its common stock at a public offering price of $45.75 per share. The size of the offering was upsized from $100 million to approximately $120 million. In addition, KYTHERA has granted the underwriters a 30-day option to purchase up to an additional 393,442 shares of common stock. All of the shares in the offering are to be sold by KYTHERA, with expected net proceeds to KYTHERA of approximately $112.2 million, after deducting underwriting discounts and commissions and estimated offering expenses, but excluding any exercise of the underwriters' option to purchase additional shares of common stock. The offering is expected to close on or about October 15, 2013, subject to customary closing conditions. J.P. Morgan Securities LLC and BofA Merrill Lynch are acting as joint book-running managers, and representatives of the underwriters for the offering. Leerink Swann LLC is also acting as a joint book-running manager. Cowen and Company, LLC is acting as co-manager. 

Company Quote

-0.35 -0.91%
10:58am EST